CN103977044B - Hooker winghead root n-butanol portion extract and its production and use - Google Patents

Hooker winghead root n-butanol portion extract and its production and use Download PDF

Info

Publication number
CN103977044B
CN103977044B CN201410217723.7A CN201410217723A CN103977044B CN 103977044 B CN103977044 B CN 103977044B CN 201410217723 A CN201410217723 A CN 201410217723A CN 103977044 B CN103977044 B CN 103977044B
Authority
CN
China
Prior art keywords
extract
hooker winghead
winghead root
butanol
butanol portion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410217723.7A
Other languages
Chinese (zh)
Other versions
CN103977044A (en
Inventor
朱国福
郭晨旭
吴迎春
潘颖宜
朱元章
陆怡
高玉琼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai University of Traditional Chinese Medicine
Original Assignee
Shanghai University of Traditional Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai University of Traditional Chinese Medicine filed Critical Shanghai University of Traditional Chinese Medicine
Priority to CN201410217723.7A priority Critical patent/CN103977044B/en
Publication of CN103977044A publication Critical patent/CN103977044A/en
Application granted granted Critical
Publication of CN103977044B publication Critical patent/CN103977044B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a kind of hooker winghead root n-butanol portion extract and its production and use.The main component of the extract is iridoid glycoside, and the preparation method of the extract is:Take hooker winghead root medicinal material, alcohol extracting under heated reflux condition, alcohol is recovered under reduced pressure in extract solution, is concentrated to give one-level extract;Add water to be suspended one-level extract again, extracted with lipophylic organic solvents, to remove oil-soluble impurities;Then extracted again with n-butanol, hooker winghead root n-butanol portion extract is obtained after recycling design.The invention also discloses purposes of the said extracted thing in antineoplastic is prepared, the extract has the effect of softening and resolving hard mass, and the performance common to malignant tumour is such as:Stagnation of blood stasis, healthy tendency virtual loss, substantive enclosed mass etc. have the effect of notable.

Description

Hooker winghead root n-butanol portion extract and its production and use
Technical field
The invention belongs to the field of Chinese medicines, more particularly to a kind of hooker winghead root n-butanol portion extract, its preparation method and Purposes in antineoplastic is prepared.
Background technology
Malignant tumour is the major disease for seriously endangering human life and health, and its death rate occupies human diseases death people Several first.GLOBOCAN (2008) report point out, global new cancer cases 12,700,000 in 2008, cancer mortality case 7600000, it is contemplated that the year two thousand thirty whole world cancer new cases will be added to 22,200,000.At present, chemotherapy is still that modern clinical tumor is controlled One of Main Means for the treatment of, but chemotherapy lacks the selectivity to normal cell and tumour cell, in the same of killing tumor cell When, also there is great damage to normal cell, not only damage the function of the vitals such as the heart, liver, lung, kidney, marrow, and destroy Immune system, self-protection barrier of the body to tumour is caused to be lost.The toxic side effect of chemotherapy and the drug resistance of tumour make mostly The treatment of number tumor patient is hard to carry on, limits the treatment intensity and frequency of use of chemotherapeutics.Therefore, it is raising intra-tumor The therapeutic effect of section, it is always the struggle mesh that researcher seek assiduously to find antineoplastic safe and effective, that toxic side effect is small Mark.
Hooker winghead root system Dipsacaceae wing head flower plants, whole world wing head flower plants there are about 25 kinds, and China only has spoon leaf Hooker winghead root Pterocephalus hookeri (C.B.Clarke) Hoeck and decomposite leaf hooker winghead root Pterocephalus Two kinds of bretschneideri (Batal.) Pretz, is distributed mainly on Tibet various regions, Qinghai, western Sichuan and the north, Yun Nanxi The ground such as the north, with root or all herbal medicine, it is Tibetan medicine's medicinal herbs most in use, is widely used in Tibetan medicinal preparation, such as 12 taste wings are first is dissipated, 20 Five tastes donkey blood ball, 20 Six-element emblic balls, nine taste green grass or young crops rocs dissipate, pomegranate Pu'an dissipates etc..Tibetan medicine thinks that hooker winghead root is cold in nature, bitter, There is clearing heat and detoxicating, wind-damp dispelling, analgesic, available for diseases such as treatment pest poison, bi Zheng, arthritis.To the medicine chemistry with Pharmacological research is in the ascendant.
The content of the invention
It is an object of the invention to provide a kind of n-butanol portion extract of hooker winghead root.
Another object of the present invention is to provide the preparation method of above-mentioned hooker winghead root n-butanol portion extract.
It is still another object of the present invention to provide above-mentioned hooker winghead root n-butanol portion extract in antineoplastic is prepared Purposes.
According to the above-mentioned purpose of the present invention, the invention provides a kind of hooker winghead root n-butanol portion extract, the extract Main component be iridoid glycoside.
The present invention also provides the preparation method of above-mentioned hooker winghead root n-butanol portion extract, and the method includes the steps of:
(1) hooker winghead root medicinal material is taken, alcohol extracting is carried out under heated reflux condition, alcohol is recovered under reduced pressure in extract solution, is concentrated to give One-level extract;
(2) add water to be suspended above-mentioned one-level extract, extracted with lipophylic organic solvents, to remove oil-soluble impurities;So Extracted again with n-butanol afterwards, the hooker winghead root n-butanol portion extract is obtained after recycling design.
Wherein, the Extraction solvent used in the alcohol extracting in above-mentioned steps (1) be methanol, ethanol, volumetric concentration be more than 50% Methanol aqueous solution or volumetric concentration be more than 50% ethanol water.The dosage of Extraction solvent used in alcohol extracting is hooker winghead root 2~10 times of quality of medicinal material.During alcohol extracting, the temperature being heated to reflux is 50~100 DEG C, and the number of heating and refluxing extraction is 1~5 It is secondary, it is heated to reflux every time 0.5~2 hour.
Lipophylic organic solvents described in above-mentioned steps (2) are petroleum ether, hexamethylene, n-hexane, benzene, carbon tetrachloride, Chloroform or dichloromethane.Lipophylic organic solvents extraction times are 1~5 time, and the solvent load extracted every time is to be extracted object Long-pending 1~5 times.
When being extracted in step (2) with n-butanol, extraction time is 1~5 time, and the dosage for adding n-butanol every time is to be extracted 1~5 times of object product.
The present invention also provide the hooker winghead root n-butanol portion extract that is prepared according to the method described above prepare it is antitumor Purposes in medicine.Specifically, i.e., using hooker winghead root n-butanol portion extract provided by the present invention as active ingredient, add Pharmaceutically acceptable carrier, with the method for Chinese medicinal of routine, various form of Chinese drug are prepared, for preventing or treating evil Property tumor disease.
Hooker winghead root n-butanol portion extract provided by the present invention, its raw material hooker winghead root crude drug source is extensive, price is low It is honest and clean, and the method kind for preparing the n-butanol portion extract is simple and easy.The present invention uses for reference clinical according to traditional Chinese medicine theory Medication experience, using traditional Tibetan medicine material hooker winghead root, its n-butanol active component is extracted, the active component can significantly inhibit a variety of The growth of tumour cell, induces liver cancer cells Hep3B apoptosis, and this result is also confirmed in nude mice experiment in vivo.Therefore, originally The involved hooker winghead root n-butanol effective part extract of invention, available for the medicine that treatment malignant tumour is made, has softening hard masses The effect of dissipating bind, the performance common to malignant tumour is such as:Stagnation of blood stasis, healthy tendency virtual loss, substantive enclosed mass etc. have significant treat Effect, exploitation is expected to be a kind of curative for effect, safe ready, toxic side effect is small, cheap antineoplastic.
Brief description of the drawings
Fig. 1 is the HPLC collection of illustrative plates of iridoid glycoside composition in hooker winghead root n-butanol portion extract;
Fig. 2 shows the inhibitory action that hooker winghead root n-butanol portion extract grows to various tumor cell strains:
Wherein, Fig. 2-a are that extract is extract to Eca-109 cells to Hep3B cell line inhibitory action figures, Fig. 2-b Strain inhibitory action figure, Fig. 2-c are that extract is extract to A549 cell lines to Hep G2 cell line inhibitory action figures, Fig. 2-d Inhibitory action figure;
Fig. 3 shows half inhibiting rate IC50 of the hooker winghead root n-butanol portion extract to various tumor cell lines;
Fig. 4 shows the influence that hooker winghead root n-butanol portion extract is bred to normal hepatocytes embryonic cell BNL-CL2;
Fig. 5 shows that the Hep3B cells of fluorescence microscope hooker winghead root n-butanol portion extract induction in vitro culture wither The morphological feature (× 400 times) died;
Fig. 6 shows transmission electron microscope observing Hep3B cell ultra micros metamorphosis (× 8200 times);
Fig. 7 shows hooker winghead root n-butanol portion extract inducing cell apoptosis and the pass of PTEN/PI3K/AKT signal paths System;Wherein, 1 control group is represented, 2 represent hooker winghead root n-butanol portion extract group (the μ g/ml of concentration 200), and 3 represent LY294002 (PI3K inhibitor) group, 4 represent the extract low concentration group treated through LY294002, and 5 represent what is treated through LY294002 Concentration group in extract, 6 represent the extract high concentration group treated through LY294002,;
Fig. 8 shows shadow of the double dye detection hooker winghead root n-butanol portion extracts of Annexin-V/PI to Hep3B Apoptosis Ring;
Fig. 9 shows hooker winghead root n-butanol portion to nude mice index and spleen index and tumor weight, the influence of nude mice body weight;Wherein, Fig. 9-a are nude mice index and spleen index figure, and Fig. 9-b are nude mouse multigraph, and Fig. 9-c are nude mice knurl weight figure, and Fig. 9-d are tumor control rate Scheme, the abscissa in each figure represents concentration group, extract high concentration in CMCNa groups, extract low concentration group, extract successively Group, positive drug fluorouracil group.
Embodiment
N-butanol portion extraction is obtained from hooker winghead root bulk drug below by way of the specific embodiment explanation present invention for preparing The method of thing, but they are not limitation of the invention.
Embodiment 1:
1.1 Med Mat Appreciation
Spoon leaf hooker winghead root Pterocephalus hookeri (C.B.Clarke) Hoeck are collected in China in April, 2012 Qinghai Province of people's republic.Identification is awarded through Chinese medicine institute of Shanghai Univ. of Traditional Chinese Medicine Zhao Zhi the Confucian or feudal ethical codes.It is big that sample is stored in Shanghai Chinese Learn Chinese pharmacology school's medicine laboratory (sample number:YSC-20120415).
It is prepared by 1.2 medicinal material extracts
Hooker winghead root medicinal material 2000g, the ethanol 7L for adding volumetric concentration to be 95%, heats refluxing extraction 3 times at 80 DEG C, every time 2h, merge extract solution, be concentrated under reduced pressure into 1/5 volume, add isometric water, evaporate into no alcohol taste, successively with 2 times of volume oil Ether, dichloromethane extract 3 times, then with 2 times of volume extracting n-butyl alcohols 3 times, merge n-butanol, recycling design obtains the positive fourth of hooker winghead root Alcohol extractive part.
Embodiment 2:
2.1 Med Mat Appreciation:With embodiment 1
It is prepared by 2.2 medicinal material extracts
Hooker winghead root medicinal material 2000g, adds absolute ethyl alcohol 7L, heats refluxing extraction 3 times at 80 DEG C, each 2h, merges extraction Liquid, 1/5 volume is concentrated under reduced pressure into, adds isometric water, evaporate into no alcohol taste, successively with 2 times of volume hexamethylenes, chloroform extraction 3 It is secondary, then with 2 times of volume extracting n-butyl alcohols 3 times, merge n-butanol, recycling design obtains hooker winghead root n-butanol portion extract.
Embodiment 3
3.1 Med Mat Appreciation:With embodiment 1
It is prepared by 3.2 medicinal material extracts
Hooker winghead root medicinal material 200g, adds methanol 900mL, heats refluxing extraction 3 times at 80 DEG C, each 2h, merges extract solution, 1/5 volume is concentrated under reduced pressure into, adds isometric water, evaporates into no alcohol taste, successively with 2 times of volume hexamethylenes, dichloromethane extraction 3 It is secondary, then with 2 times of volume extracting n-butyl alcohols 3 times, merge n-butanol, recycling design obtains hooker winghead root n-butanol portion extract.
Embodiment 4
4.1 Med Mat Appreciation:With embodiment 1
It is prepared by 4.2 medicinal material extracts
Hooker winghead root medicinal material 1000g, the ethanol 4L for adding volumetric concentration to be 75%, heats refluxing extraction 2 times at 50 DEG C, every time 0.5h, merge extract solution, be concentrated under reduced pressure into 1/5 volume, add isometric water, evaporate into no alcohol taste, successively with 1 times of volume just oneself Alkane, carbon tetrachloride extraction 3 times, then with 3 times of volume extracting n-butyl alcohols 4 times, merge n-butanol, recycling design obtains the positive fourth of hooker winghead root Alcohol extractive part.
Embodiment 5
5.1 Med Mat Appreciation:With embodiment 1
It is prepared by 5.2 medicinal material extracts
Hooker winghead root medicinal material 1000g, the methanol 3.5L for adding volumetric concentration to be 80%, heats refluxing extraction 5 times at 100 DEG C, Each 1h, merge extract solution, be concentrated under reduced pressure into 1/5 volume, add isometric water, evaporate into no alcohol taste, successively with 5 times of volumes Benzene, dichloromethane extract 3 times, then with 5 times of volume extracting n-butyl alcohols 2 times, merge n-butanol, recycling design obtains the positive fourth of hooker winghead root Alcohol extractive part.
It is first the wing of the present invention is expanded on further by test example (by taking extract prepared by embodiment 1 as an example) again below The beneficial effect of careless n-butanol portion extract, these test examples include cytotoxicity experiment and animal pharmacodynamic experiment.
Embodiment 6:The inhibitory action that hooker winghead root n-butanol portion extract grows to various tumor cell strains
6.1 experiment material
6.1.1 cell line:
Lung cancer A549 cell strain, esophageal carcinoma Eca-109 cell line strain, HepG2 cell, liver cancer Hep3B cell lines, Purchased from OEG cell institute of the Chinese Academy of Sciences, preserved by Shanghai Univ. of Traditional Chinese Medicine's prescription laboratory passage.
6.1.2 reagent:
DMEM high sugared nutrient solution (Hyclone, Thermo companies of the U.S., lot number:SH30243.01), hyclone (Gibco, Invitrogen company, lot number:100099-141), 0.25% trypsase (Gibco, Invitrogen company, is criticized Number:25200-072)
6.1.3 instrument:
Electronic balance (Shanghai Ao Haosi Instrument Ltd., model:AR124CN) CO2gas incubator (the U.S. Thermo Fisher companies, model:3111), superclean bench (Shanghai Li Shen Scientific Instruments Corporations Co., Ltd, model: HFsafe-1500), all-wave length ELIASA (gene gene companies of the U.S., model:Synergy HT), centrifuge (Sigma companies, Model:2-16PK).
6.2 experimental method:
(1) inoculating cell:Cell is made into the high sugared nutrient solution of RPMI1640 nutrient solutions and DMEM containing 10% hyclone Suspension, 96 orifice plates, every group of 4-6 multiple holes, per the μ l of pore volume 100 are inoculated into every 3000-5000 cell in hole.If Experimental agents Group, positive controls and blank control group;It is put into 37 DEG C, 5%CO2Cultivated in incubator;
(2) dosing:After cell attachment, original fluid is drawn, adds the new nutrient solution (medicine group of the medicine containing various concentrations Each concentration is closed as 500 μ g/ml, 250 μ g/ml, 125 μ g/ml, 50 μ g/ml, 25 μ g/ml, 12.5 μ g/ml, 6.25 μ g/ml;It is positive Comparison medicine vincristine concentration is 0.5 μ g/ml) per the μ l of hole 100, continue to cultivate 48h;
(3) colour generation:After cultivating 48h, 5mg/ml MTT solution 10ul are added per hole, continues to be incubated 4h, terminates culture, inhale training Hole supernatant is supported, DMSO150 μ l are added per hole, 10min is shaken, crystal is fully melted;
(4) colorimetric:490nm wavelength is selected, each hole absorbance is determined on enzyme mark detector;
(5) inhibiting rate is calculated:
6.3 experimental result
As a result as shown in Figure 2, hooker winghead root n-butanol portion extract can substantially suppress human esophagus cancer cell Eca109, people Liver cancer cells Hep3B, HepG2, the activity of human lung cancer cell A549's growth.As shown in Figure 3, half inhibiting rate (IC50) respectively For Hep3B90.92 μ g/ml, HepG2126.18 μ g/ml, A549110.4 μ g/ml, Eca109112.0 μ g/ml, illustrate the extraction Thing can suppress kinds of tumor cells growth concentration dependent.
The inhibitory action that the hooker winghead root n-butanol portion extract of embodiment 7 is bred to normal liver cell line BNL-CL2
7.1 experiment materials are the same as embodiment 6
7.2 experimental methods are the same as embodiment 6
7.3 experimental result
As shown in Figure 4, the inhibitory action that hooker winghead root n-butanol portion extract grows to normal liver cell line BNL-CL2 Unobvious, inhibiting rate are only 22.16% when maximum concentration reaches 500 μ g/ml.
The form of the fluorescence microscope hooker winghead root n-butanol portion extract inductor Hep3B Apoptosis of embodiment 8 Feature
8.1 experiment material:
PBS (Hyclone, Thermo company, lot number:), SH30256.01B Hoechst33258 dye liquors (Sigma Products, lot number:861405), it is kept in dark place.4% paraformaldehyde (Chemical Reagent Co., Ltd., Sinopharm Group, lot number: 20120514).Fluorescence microscope (Japanese OLYMPUS companies, model:IX71)
8.2 experimental method:
A) learnt from else's experience various concentrations hooker winghead root n-butanol portion extract effect 48h cell, add 4% paraformaldehyde to consolidate Determine 30min;
B) after PBS washs cell, add Hoechst33258 dye liquors (per μ l of hole 30), act on 10min;
C) PBS is washed 3 times, each 5min, adds anti-quencher mounting;
D) micro- Microscopic observation, accompanying drawing 5. is as a result seen
8.3 experimental result:
Cell after Hoechst dyeing, the distribution of cellular control unit nuclear dna is relatively uniform, and core is in circle or oval, without solid Contracting, is in faint blueness in the visual field;It is solid in fine and close dense dye, core and medication group part apoptosis, nucleus color depth Contracting, deformation.Compared with control group, the middle and high concentration group apoptotic cells increased of extract.
The form of the transmission electron microscope observing hooker winghead root n-butanol portion extract inductor Hep3B Apoptosis of embodiment 9 is special Sign
9.1 experiment material:
Transmission electron microscope (Dutch PHILIPS Co., model:Philips Tecnai-12 types), Hep3B cells, glutaraldehyde (on Marine medical pharmaceutical university experimental center for scientific technology Electron Microscopy Room provides)
9.2 experimental method:
A) various concentrations hooker winghead root n-butanol portion extract of learning from else's experience acts on 48h cell, adds penta 2 after digestion, centrifugation Aldehyde is fixed;
B) Shanghai Univ. of Traditional Chinese Medicine's experimental center for scientific technology Electron Microscopy Room embedding, section are sent
C) machine is observed on, as a result such as accompanying drawing 6
9.3 experimental result:
Control group Hep3B cell volumes are larger, and cell membrane is complete, and chromatin enriches in core, and kernel is obvious, and organelle is complete It is whole, see Fig. 6 a;And after hooker winghead root n-butanol portion extract-treated 48h, it is seen that cell volume reduces, and core has pyconsis, Chromatic agglutination in core, chromatin are unevenly assembled along under nuclear membrane, and reticulum dilatation, vacuolization increases, organelle swelling Occur Deng Apoptosis feature (see Fig. 6 b, 6c).
The hooker winghead root n-butanol portion extract inducing cell apoptosis of embodiment 10 and the pass of PTEN/PI3K/AKT signal paths System
10.1 experiment materials:
Electrophoresis apparatus (BIO-RAD companies of the U.S., type 552BR102298), transferring film instrument (BIO-RAD companies of the U.S., model: 153BR81259), multi-functional decolorization swinging table (Shanghai ZHICHENG Anaiytical Instrument Manufacturing Co., Ltd., model:ZHWY-344), constant temperature gold Category bath (Hangzhou BIOER Technology Co., Ltd, model:CHB-100), gel imaging system (BIO-RAD companies of the U.S., model: GelDoc XR), ECL luminescent solutions (Thermo companies, lot number:32106), PTEN, PI3K, AKT and p-PTEN, p-PI3K, p- AKT antibody (Rabbit mAb) is Cell Signaling Tehnology Products, the albumen Maker (U.S. Fermentas products, lot number:SM1811), other experiment reagents are purchased from Chemical Reagent Co., Ltd., Sinopharm Group.
10.2 experimental methods:
The Hep3B cells through various concentrations hooker winghead root n-butanol portion extract-treated 48h are collected respectively, and nutrient solution is inhaled Abandon, with the PBS 2 times of precooling, add 200 μ L cell pyrolysis liquid RIPA, ice bath cracking 20min, 14000r/min, 4 DEG C from Heart 20min, takes supernatant, carries out protein quantification with BCA methods, supernatant is placed in -20 DEG C of preservations after packing.Take equal protein (30 μ G) SDS-PAGE electrophoretic separation is carried out, first in the constant pressure 100V electrophoresis subsequent 150V electrophoresis 60min of 20min, then in 250mA bar Electric transferring film 90min under part, by protein delivery to pvdf membrane, 5% skimmed milk power room temperature closing 1h, it is separately added into corresponding primary antibody (internal reference GAPDH dilution factor is 1:5000, the dilution factor of primary antibody is 1:1000) stay overnight for 4 DEG C;Add corresponding HRP marks Secondary antibody (1:5000 dilutions) colour developing of room temperature 2h, ECL luminescence method, test and be repeated 3 times under the same conditions.
10.3 experimental results are shown in accompanying drawing 7
7 display can be seen that with reference to the accompanying drawings:Compared with control group, PTEN and p-PTEN expression increases, and it is dense with medicine Degree increases and ascendant trend is presented;Akt, p-Akt, PI3K, p-PI3K expression have declined, gradual with drug concentration increase expression Decline.Illustrate that the Hep3B cells through the effect of hooker winghead root n-butanol portion extract are presented with difference on protein level, pass through PTEN/PI3K/Akt signal paths work.
The double dye methods of the flow cytometer Annexin-V/PI of embodiment 11 detect hooker winghead root n-butanol portion extract to Hep3B The influence of Apoptosis
11.1 experiment materials:
Hep3B cells DMEM high sugared nutrient solution (Hyclone, Thermo companies of the U.S., lot number:SH30243.01) tire ox blood (Gibco, Invitrogen company, lot number clearly:100099-141) 0.25% trypsase, without EDTA, (Chinese medicines group chemistry Reagent Co., Ltd, lot number:20130103) 6 well culture plates (Corning companies of the U.S., model:3516), 15ml centrifuge tubes are (equal For U.S.'s Corning Products), AnnexiV/Fitc-PI kits (U.S. company BD, lot number:), flow cytometer is (beautiful BD companies of state, model:FACSCalibur), streaming pipe (U.S. company BD, model:352052)
11.2 experimental methods:
1) plate (6 orifice plates, Hep3B cells 2*10 are planted5/ hole, bed board next day dosing, action time 48h)
2) cell is collected:Medium in 6 orifice plates is sucked in corresponding 15ml centrifuge tubes respectively;It is separately added into 1mlPBS, gently swing and wash cell;Vitellophag;Centrifugation:1000rpm,5min;Operated according to kit specification, add 100 μ L/ pipe binding buffer, cell is resuspended, is separately added into 5 μ l Annexin and PI, lucifuge is incubated 30min, adds 400 μ l/ Upper machine testing in pipe binding buffer, 1h.
11.3 experimental results:See accompanying drawing 8
8 display can be seen that with reference to the accompanying drawings:As shown:Compared with control group, apoptosis-induced related PTEN and p- PTEN expression increases, and increase with drug concentration and ascendant trend is presented;Suppress apoptotic proteins Akt, p-Akt, PI3K, p-PI3K Expression has declined, and is gradually reduced with drug concentration increase expression.Illustrate through the effect of hooker winghead root n-butanol portion extract Hep3B cells are presented with difference on protein level, are worked by PTEN/PI3K/Akt signal paths.
The hooker winghead root n-butanol portion extract Anticancer effect in vivo of embodiment 12 is studied
12.1 experiment materials:
12.1.1 instrument, reagent:Mouse stomach pin, 1ml syringes, electronic balance (Industrial Co., Ltd. of upper Nereid section, YP Type), slide measure.(Chinese medicines group chemical reagent is limited by sodium carboxymethylcellulose carboxymethylcellulose sodium Company, lot number:20130113) Fluorouracil Injection (Shanghai Xudong Hipu Medicine Co., Ltd, lot number:FA1209012)
12.1.2 animal:BALB/c-nu nude mices, body weight 16-18g, 5 week old, male, had by Shanghai Si Laike experimental animals Limit responsible company to provide, experimental animal production licence:SCXK (Shanghai) 2007-0005;Raise in Shanghai Univ. of Traditional Chinese Medicine animal Experimental center no-special pathogen (SPF) environment.Temperature:20-25 DEG C, humidity 40-70%.
12.1.3 knurl kind:Hep3B cell lines
12.2 experimental methods:
12.2.1 establish liver cancer Hep3B and subcutaneously suppress knurl model:
12.2.1.1 tumour culture cell collects 5min after the Hep3B cells in exponential phase are digested with pancreatin, uses PBS is washed 2 times, and adjustment concentration of cell suspension is 1 × 107Individual/mL.
12.2.1.2 the inoculating cell of tumour culture cell is counted as 1 × 107Individual/mL, the right armpit notch graft of every nude mice Kind 2 × 106Individual cell (0.2mL/ is only).After 2-3 days, the formational situation of transplanted tumor in nude mice is observed, measures tumor size (tumour body Product TV calculation formula be:TV=1/2*a*b2, wherein a, b represent the length and width of tumour respectively), from being inoculated with, successful transplantable tumor is naked It is more consistent that tumor size is selected in mouse, gross tumor volume is up to 60~70mm3The 30 of left and right are served only for experimental study.
12.2.2 experiment packet is grouped at random by gross tumor volume size, every group 6, totally 30.
Blank control group:0.5% CMC (CMC-Na) solution is given by 0.1mL/10g body weight, gavage, is connected Continuous 21d.
Each dosage group of extract:By 0.1mL/10g dosages, gavage, continuous 21d.
Positive drug 5-FU groups ((fluorouracil group):20mg/kg times, 5-FU0.2mL/d, intraperitoneal injection, every other day one It is secondary, 21d is used in conjunction.
Each dosage group of extract --- according to each dosage group of oral liquid (μ g/ of low dosage 100 obtained by preparation method of the present invention Ml, the μ g/ml of middle dosage 300, the μ g/ml of high dose 1000), last dose next day weighs, and puts to death animal, strips tumour, spleen simultaneously Weigh.
12.2.3 observation index:1) ordinary circumstance and changes of weight of mouse are observed daily, and slide measure was used every 1 day Measure 1 nude mice knurl volume.The calculation formula of gross tumor volume (T V) is:T V=1/2*a*b2, wherein a, b represent tumour respectively Length and width.2) calculate each group knurl weight and calculate tumour inhibiting rate:Tumor-like hyperplasia (%)=(1-T/C) × 100%, wherein C are control The average knurl weight of group, T are the average knurl weight of each test group.3) index and spleen index:SI=spleen weights (mg)/10g body weight * 100%.
12.3 experimental results are shown in accompanying drawing 9.
9 display can be seen that with reference to the accompanying drawings:Compared with 0.5%CMC-Na (hydroxymethyl cellulose) control group, extract Each dosage group can reduce the knurl weight of nude mice;Each group the weight of animals is also statistically significant;In terms of immunologic mechanism is adjusted, extract Influence to index and spleen index (SI) is smaller, not statistically significant;And positive control drug fluorouracil influences to have on index and spleen index Statistical significance, therefore think that the toxic side effect of the extract is small compared with chemotherapeutic 5-FU (fluorouracil) groups.
It will be understood by those skilled in the art that the respective embodiments described above are to realize the specific embodiment of the present invention, And in actual applications, can to it, various changes can be made in the form and details, without departing from the spirit and scope of the present invention.

Claims (6)

1. purposes of the hooker winghead root n-butanol portion extract in antineoplastic is prepared, it is characterised in that the extract Main component is iridoid glycoside;
Wherein, the preparation method of the extract comprises the steps of:
(1) hooker winghead root medicinal material is taken, alcohol extracting is carried out under heated reflux condition, alcohol is recovered under reduced pressure in extract solution, is concentrated to give one-level Extract;
(2) add water to be suspended above-mentioned one-level extract, extracted with lipophylic organic solvents, to remove oil-soluble impurities;Then again Extracted with n-butanol, the hooker winghead root n-butanol portion extract is obtained after recycling design;
Wherein, the temperature being heated to reflux in step (1) is 50~100 DEG C, and the number of heating and refluxing extraction is 1~5 time, is added every time Heat backflow 0.5~2 hour.
2. purposes according to claim 1, it is characterised in that the Extraction solvent used in alcohol extracting in step (1) is methanol, The ethanol water that the methanol aqueous solution or volumetric concentration that ethanol, volumetric concentration are more than 50% are more than 50%.
3. purposes according to claim 1, it is characterised in that the dosage of the Extraction solvent used in alcohol extracting in step (1) For 2~10 times of hooker winghead root quality of medicinal material.
4. purposes according to claim 1, it is characterised in that the lipophylic organic solvents described in step (2) are oil Ether, hexamethylene, n-hexane, benzene, carbon tetrachloride, chloroform or dichloromethane.
5. purposes according to claim 1, it is characterised in that the number that lipophylic organic solvents extract in step (2) is 1 ~5 times, the solvent load extracted every time is 1~5 times of extract volume.
6. purposes according to claim 1, it is characterised in that the number that n-butanol extracts in step (2) is 1~5 time, often The dosage of secondary addition n-butanol is 1~5 times of extract volume.
CN201410217723.7A 2014-05-20 2014-05-20 Hooker winghead root n-butanol portion extract and its production and use Expired - Fee Related CN103977044B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410217723.7A CN103977044B (en) 2014-05-20 2014-05-20 Hooker winghead root n-butanol portion extract and its production and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410217723.7A CN103977044B (en) 2014-05-20 2014-05-20 Hooker winghead root n-butanol portion extract and its production and use

Publications (2)

Publication Number Publication Date
CN103977044A CN103977044A (en) 2014-08-13
CN103977044B true CN103977044B (en) 2017-11-14

Family

ID=51269371

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410217723.7A Expired - Fee Related CN103977044B (en) 2014-05-20 2014-05-20 Hooker winghead root n-butanol portion extract and its production and use

Country Status (1)

Country Link
CN (1) CN103977044B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110885385B (en) * 2019-11-19 2020-09-25 西南大学 Pterocephalus hookeri toxin A, application thereof and preparation method of pterocephalus hookeri extract with low liver injury toxicity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3887596B2 (en) * 2002-11-05 2007-02-28 株式会社ノエビア Skin preparation for moisturizing and skin preparation for improving rough skin
CN102614230B (en) * 2011-03-09 2014-01-08 成都中医药大学 Medicinal composition for treating rheumatoid arthritis and preparation method and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
植物中环烯醚萜类化合物研究进展;董娟娥等;《西北林学院学报》;20041231;第19卷(第3期);第131-135页和142页,第134页左栏第2段和第3段 *
翼首草总皂苷对体外培养的肿瘤细胞增殖的影响;雷旭东等;《时珍国医国药》;20111231;第22卷(第6期);第1518-1519页,尤其是第1518页左栏第1段 *

Also Published As

Publication number Publication date
CN103977044A (en) 2014-08-13

Similar Documents

Publication Publication Date Title
Siriwatanametanon et al. Traditionally used Thai medicinal plants: in vitro anti-inflammatory, anticancer and antioxidant activities
CN101554462B (en) Medicament for curing cancer
Bharshiv et al. Immunomodulatory activity of aqueous extract of Nyctanthes arbor-tristis flowers with particular reference to splenocytes proliferation and cytokines induction
CN102058609A (en) Application of polydatin to preparing antineoplastic drug
CN108926584A (en) The antimicrobial purposes of chimonanthea extract
CN102276619A (en) Method for preparing sodium canthanridate
CN103977044B (en) Hooker winghead root n-butanol portion extract and its production and use
Begum Phytochemical and pharmacological investigation of Carica papaya leaf
CN105541562B (en) Sesquiterpene quinone compound Dysiherbols A and preparation method and application thereof
CN103550323B (en) A kind of purposes and preparation method with the waistcoat seed extract of anti-tumor activity
CN108079169A (en) For preventing and treating the Chinese medicine composition of atherosclerosis and its complication, Chinese medicine preparation and application
CN101569654B (en) Application of pigeon pea stilbene acid in the preparation of antitumor drug
CN102675270B (en) Method for extracting anticancer compound from henbane, and application of anticancer compound
CN105669630A (en) Extraction method of deoxydihydroxanthoangelol H chalcone suitable to serve as liver cancer targeted drug
CN102805829B (en) Preparation method of rhizoma smilacis glabrae extract and applications thereof in tumor treatment
CN106177035B (en) Preparation method and application of effective rosa chinensis flower extract with blood sugar reducing and anticancer functions
Adam et al. Phytochemical Screening and Biological effect of Indigenous Medicinal plant Origanum majorana extracts
CN105412083B (en) The application of isopimpinellin
CN104257641B (en) A kind of C36Polyacetylene compound and preparation thereof and application
CN107739360A (en) Phenolic compound graphislactoneA preparation method and applications in Himalayan mayapple fruit
CN108926585A (en) Application of the wintersweet genus plants extract in pharmacy
CN109602775B (en) Application of chicory alcohol extract in preparation of anti-breast cancer drugs
Sultan antipyretic activity of hydro-methanolic extract of Trachyspermum ammi linn. seeds in rabbits
CN106266473A (en) A kind of green Bulbus Allii extract with antihepatocarcinoma effect and Preparation method and use
Shah et al. Antiproliferative and Antioxidant potential of different extracts of Fritillaria roylei

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20171114

Termination date: 20200520